Minimal Residual Disease Defines the Risk and Time to Biochemical Failure in Patients with pT2 and pT3a Prostate Cancer Treated with Radical Prostatectomy: an Observational Prospective Study.

CONCLUSIONS: The sub-type of MRD identifies Gleason 6 pT2 patients with a poor prognosis and Gleason 7 pT3a patients with a good prognosis and could be used to classify men according to personal risk characteristics for the use of adjuvant treatment.(244 words). PMID: 31912475 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31912475?dopt=Abstract

Source: Urology Journal - January 3, 2020 Category: Urology & Nephrology Authors: Murray NP, Aedo S, Fuentealba C, Reyes E, Salazar A, Lopez MA, Minzer S, Orrego S, Guzman E Tags: Urol J Source Type: research